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Introduction
Granuloma faciale is an uncommon, idiopathic, 
inflammatory dermatosis that usually affects the 
face.1 Despite its benign nature, the condition tends 
to be persistent, can be cosmetically distressing and is 
notoriously difficult to eradicate completely.2 We report 
a case of successful treatment of granuloma faciale using 




A 39-year-old English lady with Fitzpatrick skin phototype 
II, presented to our Dermatology Department with 3 
sharply-demarcated, reddish-brown, indurated plaques 
with accentuated follicular openings and few superficial 
telangiectases. These were present on both cheeks and the 
tip of the nose. The patient had been previously diagnosed 
with granuloma faciale in the United Kingdom 6 months 
previously and was started on dapsone 50 mg daily, to 
which there was no visible response.
The patient then moved to Malta where dapsone was 
stopped and the lesion on the right cheek biopsied. The 
biopsy showed a dense neutrophilic and eosinophilic 
infiltrate within the papillary and reticular dermis, with 
a prominent Grenz zone, confirming the diagnosis of 
granuloma faciale.
At this point, treatment with pulsed dye laser was 
attempted. A test area in the right cheek lesion underwent 
two treatments with a ScleroPlus pulsed dye laser 
(Candela Corporation, Wayland, Mass) with cryogen-
spray dynamic cooling. A wavelength of 595 nm and 
pulse duration of 1.5 ms were used, with a 7 mm spot 
at a fluence of 8.5 J/cm2 for the first session and 9.5 J/
cm2 for the second session, carried out after an interval 
of 8 weeks. There was no visible improvement with this 
treatment. 
The patient was lost to follow-up but re-presented 5 years 
later with the same lesions, which by then had become 
more prominent. She was prescribed mometasone 
0.1% ointment once daily for 2 months, with no visible 
improvement. Tacrolimus 0.1% ointment twice daily was 
then added to the mometasone ointment for another 2 
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Abstract
Introduction: Granuloma faciale is an uncommon inflammatory dermatosis which usually 
affects the face and is often resistant to treatment.
Case Report: A 39-year-old English lady with Fitzpatrick skin phototype II presented 
with typical lesions of granuloma faciale, confirmed on biopsy, on her cheeks and nose. 
Treatment with ScleroPlus pulsed dye laser (Candela Corporation, Wayland, Mass) 
produced no visible improvement. The patient re-presented 5 years later with the same 
lesions, now more prominent. No improvement was noted with topical mometasone, 
however addition of topical tacrolimus caused significant flattening. Since the erythema 
and telangiectases persisted, treatment with ScleroPlus pulsed dye laser was re-attempted. 
Treatments were performed with a wavelength of 595 nm, pulse duration of 1.5 ms and 
7 mm spot at a fluence of 8.5 J/cm2 in the first session and 9.5 J/cm2 in the subsequent 2 
sessions. This resulted in complete resolution without scarring or pigmentary change. There 
was no recurrence at follow-up one year later.
Conclusion: Our observation supports the use of combination therapy in resistant cases 
of granuloma faciale. One such combination would be the application of a topical 
corticosteroid and tacrolimus followed by pulsed dye laser.
Keywords: Lasers; Dye pulsed; Granuloma; Tacrolimus; Mometasone.
*Correspondence to
Daniel Micallef, M.D; Higher 
Specialist Trainee in Dermatology, 
Sir Paul Boffa Hospital, Harper Lane, 
Floriana FLR1940, Malta.  
Tel: +35621234491;
Email: daniel.b.micallef@gov.mt




J Lasers Med Sci 2017 Spring;8(2):95-97
http://www.journals.sbmu.ac.ir/jlms
Micallef and Boffa
 Journal of Lasers in Medical Sciences  Volume 8, Number 2, Spring 201796
months. This caused significant flattening of the lesions 
but the erythema and telangiectases persisted (Figure 1A 
and 1B). At this point, treatment with ScleroPlus pulsed 
dye laser with cryogen-spray dynamic cooling was re-
attempted. Treatments were performed with a wavelength 
of 595 nm, pulse duration of 1.5 ms and a 7 mm spot at a 
fluence of 8.5 J/cm2 in the first session and 9.5 J/cm2 in the 
subsequent 2 sessions, after intervals of 8 weeks. 
There was an impressive response to pulsed dye laser, 
with complete resolution of the lesions without scarring 
or pigmentary change (Figures 1 and 2). There was no 
recurrence at follow-up one year later.
Discussion
Granuloma faciale is an uncommon dermatosis 
characterized by one or more well-demarcated, infiltrated 
red-brown nodules or plaques, most commonly in adult 
Caucasian men.1 Sites of predilection are the sides and tip 
of the nose (37%), the pre-auricular area (22%), cheeks 
(22%), forehead (15%) and helix of the ear (4%).3 Extra-
facial involvement has been rarely reported. The condition 
may be difficult to diagnose clinically and in one study 
of 66 patients with histologically-confirmed granuloma 
faciale, it was suspected clinically in only 10 cases; the 
commonest differential diagnoses were sarcoidosis, 
lymphocytic infiltrates, lymphomas, basal cell carcinoma, 
fixed drug eruption, lupus erythematous and erythema 
elevatum diutinum.4 
Histological features of granuloma faciale include a 
dense inflammatory infiltrate in the upper two thirds 
of the dermis with a characteristic uninvolved Grenz 
zone beneath the epidermis and often around the 
pilosebaceous follicles.5 Blood vessels in the upper dermis 
are usually dilated and extravasation of erythrocytes and 
hemosiderin deposition is common.5 
Several treatment options have been proposed for 
granuloma faciale; however, no modality has been shown 
to be consistently effective.3 Some degree of success has 
been reported with topical or intralesional corticosteroids, 
however, they rarely yield satisfactory long-term results.6 
In addition, potential side effects particularly skin 
atrophy limit their prolonged use.3 Topical tacrolimus as 
monotherapy may also be helpful.7 It has been suggested 
that the accumulation of the inflammatory infiltrate 
in granuloma faciale is mediated by interferon-γ.8 
Tacrolimus is thought to be useful, since it inhibits the 
release of this inflammatory mediator.8 While it has a 
favorable side-effect profile, most reports demonstrate 
incomplete resolution with this agent.8-10 
There are isolated case reports on the use of systemic agents 
such as dapsone, colchicine, anti-malarials, isoniazid 
and clofazimine; however, they are neither consistently 
effective nor without risks of adverse effects.2,3
Various lasers have been used to treat granuloma faciale, 
with variable efficacy. The carbon dioxide laser was one 
of the first lasers used.3 This laser causes non-selective 
vaporization of tissue with significant hypopigmentation 
and scarring.3 The more recent use of a scanning-
assisted CO2 laser can however, reduce these adverse 
effects.11 There are a few cases in which the argon laser 
was effective,12 however, this benefit was limited by 
the development of collagenous scars.1,2 The 532 nm 
potassium titanyl phosphate (KTP) laser has also been 
reported to be useful, but only isolated case reports are 
available.2
The reddish-brown hue and telangiectases of granuloma 
faciale suggest that pulsed dye laser could be effective via 
selective photothermolysis affecting the microvasculature 
and immunologic activation of the treated skin.1,3 Short-
term pain and bruising are common adverse effects of 
pulsed dye laser, but long-term side effects are minimal 
or absent.1 The first 2 reported cases of granuloma faciale 
successfully treated with pulsed dye laser involved an 
11-year-old child and a 41-year-old man.3,13 There are 
at least 8 other cases reporting a good response and 
3 cases reporting a poor response to pulsed dye laser; 
however, complete resolution is unusual. In some cases, 
partial improvement was noted with potent topical 
corticosteroids used prior to laser therapy.1 However, 
there are no case reports in which topical tacrolimus, with 
or without topical corticosteroids, was used prior to laser 
therapy. 
Cutaneous vascular lesions that are thick, deep or raised 
above the skin surface may respond poorly to pulsed 
dye laser.14 In our case, pulsed dye laser was ineffective 
when the lesions were still raised and indurated. However, 
pre-treatment with topical mometasone and tacrolimus, 
which both target the inflammatory cascades, resulted in 
flattening of the lesions, which subsequently were fully 
eradicated with pulsed dye laser. To our knowledge, this is 
Figure 1. Photographs of the Lesions After Application of Topical 
Mometasone and Tacrolimus, Before Treatment With Pulsed Dye 
Laser.
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the first reported case of such a combination being used 
prior to pulsed dye laser therapy.
Conclusion
While monotherapy is sometimes effective in granuloma 
faciale, complete clearance is unusual. Our observation 
supports using combination therapy, particularly 
in resistant cases. One such combination would be 
the application of topical anti-inflammatory agents 
(corticosteroid and tacrolimus), followed by treatment 
with pulsed dye laser.
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